RE and Probiotics in MAFLD/NAFLD | MicrobiomeTrials← Back to trialsNCT06563921
RE and Probiotics in MAFLD/NAFLD
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-11-10Est. Completion: 2031-04-10
Enrollment target: 180 participants Other microbiome trials you might be interested in
Lung Non-Small Cell CarcinomaLung Non-Small Cell Squamous CarcinomaLung Non-Squamous Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of …
Anchorage, United StatesEst. completion Jan 31, 2030
Obesity
Background:
Obesity affects 1 in 5 children in the United States. Childhood obesity often persists into adolescence and…
Research Triangle Park, United StatesEst. completion Dec 23, 2036
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
This study will test a Regeneron study drug called ALN-CIDEB to find out whether it may help treat a liver disease calle…
Tucson, United StatesEst. completion Jan 29, 2029